Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2017-12

AUTHORS

Muhammad Masab, Muhammad Wasif Saif

ABSTRACT

INTRODUCTION: Metastatic neuroendocrine tumors (NETs) are associated with carcinoid syndrome that is typically characterized by diarrhea, cutaneous flushing and bronchospasm. Treatment with somatostatin analogues (SSA) improves the symptom burden but a significant proportion of patients stop responding to SSA therapy eventually. Novel agents with the potential to effectively control the symptoms are urgently needed. METHODS: This article reviews an in-depth analysis of the phase I-III clinical trials determining the clinical rationale for the use of tryptophan hydroxylase inhibitor, telotristat ethyl in patients with well-differentiated metastatic NETs and uncontrolled carcinoid syndrome. DISCUSSION: Telotristat ethyl has already been approved for the treatment of inadequately controlled carcinoid syndrome symptoms in metastatic NET patients on SSA therapy. Results from multiple phase I-III clinical studies of telotristat ethyl therapy have reported a significant decrease in the daily bowel movement frequency, increase in quality of life and the subsequent decrease in annual health costs related to carcinoid syndrome symptoms in NET patients. FUTURE DIRECTIONS: The associated decrease in urinary 5-hydroxyindoleacetic acid (u5-HIAA) provides evidence that telotristat ethyl effectively decreases serotonin production, and therefore, offers a rationale to investigate this agent to mitigate serotonin-mediated complications in this patient population, especially cardiac valvular disease or mesenteric fibrosis. More... »

PAGES

1055-1062

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s00280-017-3462-y

DOI

http://dx.doi.org/10.1007/s00280-017-3462-y

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1092291880

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29051994


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Administration, Oral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diarrhea", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Malignant Carcinoid Syndrome", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Neuroendocrine Tumors", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Phenylalanine", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Pyrimidines", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Albert Einstein Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.239276.b", 
          "name": [
            "Albert Einstein Medical Center, Philadelphia, PA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Masab", 
        "givenName": "Muhammad", 
        "id": "sg:person.0761661517.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761661517.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tufts Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.67033.31", 
          "name": [
            "Section of GI Cancers and Experimental Therapeutics, Division of GI Oncology and Experimental Therapeutics, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, 02111, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Saif", 
        "givenName": "Muhammad Wasif", 
        "id": "sg:person.0770517140.13", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770517140.13"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.4155/cli.15.10", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1015991091"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0b013e3182328045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018322394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/mpa.0b013e3182328045", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1018322394"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12672-015-0233-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023462638", 
          "https://doi.org/10.1007/s12672-015-0233-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt377", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025234909"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1517/14656566.2016.1127914", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029958692"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2147/ott.s72155", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029987038"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000080731", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035837670"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdq670", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039513624"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0000000000000146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043731198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1097/cco.0000000000000146", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043731198"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1159/000051862", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045396458"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199903183401107", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1046339720"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm196711232772101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047135119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1530/erc-14-0173", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048222451"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1210/jc.2014-2247", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1064295249"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.6092/1590-8577/2287", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1078878429"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079293582", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079293583", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdw369.07", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083558861"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2174/1871520617666170213113401", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1083989344"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2017-12", 
    "datePublishedReg": "2017-12-01", 
    "description": "INTRODUCTION: Metastatic neuroendocrine tumors (NETs) are associated with carcinoid syndrome that is typically characterized by diarrhea, cutaneous flushing and bronchospasm. Treatment with somatostatin analogues (SSA) improves the symptom burden but a significant proportion of patients stop responding to SSA therapy eventually. Novel agents with the potential to effectively control the symptoms are urgently needed.\nMETHODS: This article reviews an in-depth analysis of the phase I-III clinical trials determining the clinical rationale for the use of tryptophan hydroxylase inhibitor, telotristat ethyl in patients with well-differentiated metastatic NETs and uncontrolled carcinoid syndrome.\nDISCUSSION: Telotristat ethyl has already been approved for the treatment of inadequately controlled carcinoid syndrome symptoms in metastatic NET patients on SSA therapy. Results from multiple phase I-III clinical studies of telotristat ethyl therapy have reported a significant decrease in the daily bowel movement frequency, increase in quality of life and the subsequent decrease in annual health costs related to carcinoid syndrome symptoms in NET patients.\nFUTURE DIRECTIONS: The associated decrease in urinary 5-hydroxyindoleacetic acid (u5-HIAA) provides evidence that telotristat ethyl effectively decreases serotonin production, and therefore, offers a rationale to investigate this agent to mitigate serotonin-mediated complications in this patient population, especially cardiac valvular disease or mesenteric fibrosis.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s00280-017-3462-y", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isPartOf": [
      {
        "id": "sg:journal.1088364", 
        "issn": [
          "0344-5704", 
          "1432-0843"
        ], 
        "name": "Cancer Chemotherapy and Pharmacology", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "6", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "80"
      }
    ], 
    "name": "Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea", 
    "pagination": "1055-1062", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "c588db1d71e1b38244b3bceda0c110e4c000da7cb16077596bc2bb7b595bb16d"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29051994"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "7806519"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s00280-017-3462-y"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1092291880"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s00280-017-3462-y", 
      "https://app.dimensions.ai/details/publication/pub.1092291880"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-10T14:23", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8660_00000601.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs00280-017-3462-y"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s00280-017-3462-y'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s00280-017-3462-y'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s00280-017-3462-y'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s00280-017-3462-y'


 

This table displays all metadata directly associated to this object as RDF triples.

171 TRIPLES      21 PREDICATES      57 URIs      30 LITERALS      18 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s00280-017-3462-y schema:about N014d351033394ce9a484d290a86b21a4
2 N423bc6b78b974448a3249b9d03040372
3 N61c9b77d71b24cddb0718b69f4a8c76e
4 N8d791373ec654809b809592dbdbe61d8
5 N8da2af2406b5469b9c9a33523aa2a37c
6 Na5a51031f3464e20bcc594e367cadb64
7 Na932d37f4b59449a9c0e3e9ff6b5964a
8 Nea8a5cf163774d85a2dc59f054397cad
9 Nefb22f0e6c334aae83fb29b9c131e962
10 anzsrc-for:11
11 anzsrc-for:1103
12 schema:author N37d002a14bf14337a98f5c52d395360d
13 schema:citation sg:pub.10.1007/s12672-015-0233-2
14 https://app.dimensions.ai/details/publication/pub.1079293582
15 https://app.dimensions.ai/details/publication/pub.1079293583
16 https://doi.org/10.1056/nejm196711232772101
17 https://doi.org/10.1056/nejm199903183401107
18 https://doi.org/10.1093/annonc/mdq670
19 https://doi.org/10.1093/annonc/mdt377
20 https://doi.org/10.1093/annonc/mdw369.07
21 https://doi.org/10.1097/cco.0000000000000146
22 https://doi.org/10.1097/mpa.0b013e3182328045
23 https://doi.org/10.1159/000051862
24 https://doi.org/10.1159/000080731
25 https://doi.org/10.1210/jc.2014-2247
26 https://doi.org/10.1517/14656566.2016.1127914
27 https://doi.org/10.1530/erc-14-0173
28 https://doi.org/10.2147/ott.s72155
29 https://doi.org/10.2174/1871520617666170213113401
30 https://doi.org/10.4155/cli.15.10
31 https://doi.org/10.6092/1590-8577/2287
32 schema:datePublished 2017-12
33 schema:datePublishedReg 2017-12-01
34 schema:description INTRODUCTION: Metastatic neuroendocrine tumors (NETs) are associated with carcinoid syndrome that is typically characterized by diarrhea, cutaneous flushing and bronchospasm. Treatment with somatostatin analogues (SSA) improves the symptom burden but a significant proportion of patients stop responding to SSA therapy eventually. Novel agents with the potential to effectively control the symptoms are urgently needed. METHODS: This article reviews an in-depth analysis of the phase I-III clinical trials determining the clinical rationale for the use of tryptophan hydroxylase inhibitor, telotristat ethyl in patients with well-differentiated metastatic NETs and uncontrolled carcinoid syndrome. DISCUSSION: Telotristat ethyl has already been approved for the treatment of inadequately controlled carcinoid syndrome symptoms in metastatic NET patients on SSA therapy. Results from multiple phase I-III clinical studies of telotristat ethyl therapy have reported a significant decrease in the daily bowel movement frequency, increase in quality of life and the subsequent decrease in annual health costs related to carcinoid syndrome symptoms in NET patients. FUTURE DIRECTIONS: The associated decrease in urinary 5-hydroxyindoleacetic acid (u5-HIAA) provides evidence that telotristat ethyl effectively decreases serotonin production, and therefore, offers a rationale to investigate this agent to mitigate serotonin-mediated complications in this patient population, especially cardiac valvular disease or mesenteric fibrosis.
35 schema:genre research_article
36 schema:inLanguage en
37 schema:isAccessibleForFree false
38 schema:isPartOf N46e4d553df6841a68a2d2665a3527fdf
39 Na96446013e544d769372529fa37c1679
40 sg:journal.1088364
41 schema:name Telotristat ethyl: proof of principle and the first oral agent in the management of well-differentiated metastatic neuroendocrine tumor and carcinoid syndrome diarrhea
42 schema:pagination 1055-1062
43 schema:productId N19d59c26ea3840b5a40cc3a909bc79fa
44 N50e9be6008d646869e18e9893769c48a
45 N87832767a83541d790e96b04d9be38ef
46 N9515f07fdcab4a29a8e4f52370d331d5
47 Nd018ab64c29e4ea18c710f2e4faa9799
48 schema:sameAs https://app.dimensions.ai/details/publication/pub.1092291880
49 https://doi.org/10.1007/s00280-017-3462-y
50 schema:sdDatePublished 2019-04-10T14:23
51 schema:sdLicense https://scigraph.springernature.com/explorer/license/
52 schema:sdPublisher N27fbb2a4b13b428b878e408760de359a
53 schema:url https://link.springer.com/10.1007%2Fs00280-017-3462-y
54 sgo:license sg:explorer/license/
55 sgo:sdDataset articles
56 rdf:type schema:ScholarlyArticle
57 N014d351033394ce9a484d290a86b21a4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
58 schema:name Pyrimidines
59 rdf:type schema:DefinedTerm
60 N19d59c26ea3840b5a40cc3a909bc79fa schema:name pubmed_id
61 schema:value 29051994
62 rdf:type schema:PropertyValue
63 N27fbb2a4b13b428b878e408760de359a schema:name Springer Nature - SN SciGraph project
64 rdf:type schema:Organization
65 N37d002a14bf14337a98f5c52d395360d rdf:first sg:person.0761661517.10
66 rdf:rest N4e7264faa9874e098076985c1a09d299
67 N423bc6b78b974448a3249b9d03040372 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
68 schema:name Female
69 rdf:type schema:DefinedTerm
70 N46e4d553df6841a68a2d2665a3527fdf schema:volumeNumber 80
71 rdf:type schema:PublicationVolume
72 N4e7264faa9874e098076985c1a09d299 rdf:first sg:person.0770517140.13
73 rdf:rest rdf:nil
74 N50e9be6008d646869e18e9893769c48a schema:name doi
75 schema:value 10.1007/s00280-017-3462-y
76 rdf:type schema:PropertyValue
77 N61c9b77d71b24cddb0718b69f4a8c76e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Administration, Oral
79 rdf:type schema:DefinedTerm
80 N87832767a83541d790e96b04d9be38ef schema:name nlm_unique_id
81 schema:value 7806519
82 rdf:type schema:PropertyValue
83 N8d791373ec654809b809592dbdbe61d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
84 schema:name Malignant Carcinoid Syndrome
85 rdf:type schema:DefinedTerm
86 N8da2af2406b5469b9c9a33523aa2a37c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
87 schema:name Phenylalanine
88 rdf:type schema:DefinedTerm
89 N9515f07fdcab4a29a8e4f52370d331d5 schema:name dimensions_id
90 schema:value pub.1092291880
91 rdf:type schema:PropertyValue
92 Na5a51031f3464e20bcc594e367cadb64 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
93 schema:name Male
94 rdf:type schema:DefinedTerm
95 Na932d37f4b59449a9c0e3e9ff6b5964a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
96 schema:name Neuroendocrine Tumors
97 rdf:type schema:DefinedTerm
98 Na96446013e544d769372529fa37c1679 schema:issueNumber 6
99 rdf:type schema:PublicationIssue
100 Nd018ab64c29e4ea18c710f2e4faa9799 schema:name readcube_id
101 schema:value c588db1d71e1b38244b3bceda0c110e4c000da7cb16077596bc2bb7b595bb16d
102 rdf:type schema:PropertyValue
103 Nea8a5cf163774d85a2dc59f054397cad schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
104 schema:name Diarrhea
105 rdf:type schema:DefinedTerm
106 Nefb22f0e6c334aae83fb29b9c131e962 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
107 schema:name Humans
108 rdf:type schema:DefinedTerm
109 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
110 schema:name Medical and Health Sciences
111 rdf:type schema:DefinedTerm
112 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
113 schema:name Clinical Sciences
114 rdf:type schema:DefinedTerm
115 sg:journal.1088364 schema:issn 0344-5704
116 1432-0843
117 schema:name Cancer Chemotherapy and Pharmacology
118 rdf:type schema:Periodical
119 sg:person.0761661517.10 schema:affiliation https://www.grid.ac/institutes/grid.239276.b
120 schema:familyName Masab
121 schema:givenName Muhammad
122 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0761661517.10
123 rdf:type schema:Person
124 sg:person.0770517140.13 schema:affiliation https://www.grid.ac/institutes/grid.67033.31
125 schema:familyName Saif
126 schema:givenName Muhammad Wasif
127 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0770517140.13
128 rdf:type schema:Person
129 sg:pub.10.1007/s12672-015-0233-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023462638
130 https://doi.org/10.1007/s12672-015-0233-2
131 rdf:type schema:CreativeWork
132 https://app.dimensions.ai/details/publication/pub.1079293582 schema:CreativeWork
133 https://app.dimensions.ai/details/publication/pub.1079293583 schema:CreativeWork
134 https://doi.org/10.1056/nejm196711232772101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047135119
135 rdf:type schema:CreativeWork
136 https://doi.org/10.1056/nejm199903183401107 schema:sameAs https://app.dimensions.ai/details/publication/pub.1046339720
137 rdf:type schema:CreativeWork
138 https://doi.org/10.1093/annonc/mdq670 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039513624
139 rdf:type schema:CreativeWork
140 https://doi.org/10.1093/annonc/mdt377 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025234909
141 rdf:type schema:CreativeWork
142 https://doi.org/10.1093/annonc/mdw369.07 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083558861
143 rdf:type schema:CreativeWork
144 https://doi.org/10.1097/cco.0000000000000146 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043731198
145 rdf:type schema:CreativeWork
146 https://doi.org/10.1097/mpa.0b013e3182328045 schema:sameAs https://app.dimensions.ai/details/publication/pub.1018322394
147 rdf:type schema:CreativeWork
148 https://doi.org/10.1159/000051862 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045396458
149 rdf:type schema:CreativeWork
150 https://doi.org/10.1159/000080731 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035837670
151 rdf:type schema:CreativeWork
152 https://doi.org/10.1210/jc.2014-2247 schema:sameAs https://app.dimensions.ai/details/publication/pub.1064295249
153 rdf:type schema:CreativeWork
154 https://doi.org/10.1517/14656566.2016.1127914 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029958692
155 rdf:type schema:CreativeWork
156 https://doi.org/10.1530/erc-14-0173 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048222451
157 rdf:type schema:CreativeWork
158 https://doi.org/10.2147/ott.s72155 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029987038
159 rdf:type schema:CreativeWork
160 https://doi.org/10.2174/1871520617666170213113401 schema:sameAs https://app.dimensions.ai/details/publication/pub.1083989344
161 rdf:type schema:CreativeWork
162 https://doi.org/10.4155/cli.15.10 schema:sameAs https://app.dimensions.ai/details/publication/pub.1015991091
163 rdf:type schema:CreativeWork
164 https://doi.org/10.6092/1590-8577/2287 schema:sameAs https://app.dimensions.ai/details/publication/pub.1078878429
165 rdf:type schema:CreativeWork
166 https://www.grid.ac/institutes/grid.239276.b schema:alternateName Albert Einstein Medical Center
167 schema:name Albert Einstein Medical Center, Philadelphia, PA, USA
168 rdf:type schema:Organization
169 https://www.grid.ac/institutes/grid.67033.31 schema:alternateName Tufts Medical Center
170 schema:name Section of GI Cancers and Experimental Therapeutics, Division of GI Oncology and Experimental Therapeutics, Tufts Medical Center, Tufts University School of Medicine, 800 Washington Street, 02111, Boston, MA, USA
171 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...